Skip to content

Public FDA record

Z-2266-2014: Gelweave (TM) Vascular Prostheses Manufactured by - VASCUTEK Ltd a TERUMO company

Recall record Z-2266-2014 for Vascutek, Ltd.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2266-2014
Company in FDA record
Vascutek, Ltd.
FDA classification date
Aug 18, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The cautery that is provided with the Gelweave graft in the box has a shorter shelf life indicated on its label, versus that of the graft (4 years and 5 years, respectively).

Source facts

Action
Vascutek sent an Urgent Field Safety Notice dated July 15, 2014, to all affect customers. The letter identified the product the problem and the action needed to be taken by the customer. User Instructions: A. Vascutek advises that you ensure suitable equipment is available prior to implantation to trim the graft if required. B. For product received with a cautery in the interim, Vascutek request that you check the shelf life of each product before every operation. If you find that the cautery is out of date, remove and discard the cautery. If you require an appropriate cautery supplied as a separate item, please contact your local sales representative for a referral. C.Vascutek are taking this opportunity to reinforce the cautions from the Gelweave TM Vascular Prostheses IFU regarding soaking of the graft in saline to prevent focal burning if a cautery is to be used. This statement is already included in the IFU and now appears in bold, red font to ensure appropriate awareness. This notice needs to be passed on to all persons who need to be aware within your organization or to any organization where the devices have been transferred or distributed. Please maintain awareness of this Field Safety Notice while all actions are taken in your organization and until these products are provided without the cautery. Please return the User Return Slip by e-mail or fax to the Distributor's address given on page 3. This action by Vascutek Ltd. is being taken with the knowledge of the National Competent Authority Medicines and Healthcare Products Regulatory Agency (MHRA). If you have any further questions or comments, please do not hesitate to contact us at tcvs.recall@terumomedical.com. Return Completed Form immediately fax to (734) 741-6149. If required, your Vascutek Ltd. representative can discuss and provide more information on the use of cautery with Vascutek products. For further questions call (800) 262-3304 ext. 6056
Initiated
2014-07-15
Root cause
Incorrect or no expiration date
Terminated
2015-03-19
Distribution
Nationwide Distribution including the states of : AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI and WV.
Recall number
Z-2266-2014
Recall status
Terminated
CDRH record ID
129138
FDA classified
2014-08-18
Recall event number
68952

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗